Pediatric Cardiomyopathy Mutation Analysis
Launched by INDIANA UNIVERSITY · Apr 28, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Pediatric Cardiomyopathy Mutation Analysis, is focused on understanding the genetic causes of cardiomyopathy, a condition that affects the heart muscle and can lead to serious health issues. Researchers are looking for information from children and their families who have been diagnosed with different types of cardiomyopathy, including dilated, hypertrophic, restrictive, arrhythmogenic right ventricular, and left ventricular non-compaction cardiomyopathy. The findings from this study will help improve genetic counseling and deepen our understanding of how the heart works normally and when it doesn't.
To participate, individuals must either have a diagnosis of cardiomyopathy or be family members of someone who does. Unfortunately, those without cardiomyopathy or their relatives cannot take part in this study. If you decide to join, you'll be contributing important information that could help future patients and families affected by this condition. The trial is currently recruiting participants of all ages and genders, so you can reach out to learn more about how you can get involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects with cardiomyopathy
- • Family members of subjects with cardiomyopathy
- Exclusion Criteria:
- • Subjects without cardiomyopathy
- • Family members of subjects without cardiomyopathy
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Stephanie Ware, MD, PhD
Principal Investigator
IU School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials